Creative Planning - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 39 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$11,000
-62.1%
111,953
+42.0%
0.00%
Q2 2016$29,000
-3.3%
78,8180.0%0.00%
Q1 2016$30,000
-6.2%
78,818
-3.7%
0.00%
Q4 2015$32,000
-28.9%
81,818
+3.8%
0.00%
Q3 2015$45,000
-25.0%
78,818
-29.5%
0.00%
-100.0%
Q2 2015$60,000
-18.9%
111,818
+23.7%
0.00%0.0%
Q1 2015$74,000
+23.3%
90,400
+19.9%
0.00%0.0%
Q4 2014$60,000
+20.0%
75,400
+54.2%
0.00%0.0%
Q3 2014$50,000
+85.2%
48,900
+55.7%
0.00%
Q2 2014$27,00031,4000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,226,961$824,0000.12%
HOME FEDERAL BANK OF TENNESSEE 100,000$37,0000.02%
Cutter & CO Brokerage, Inc. 84,500$31,0000.01%
PRINCETON CAPITAL MANAGEMENT LLC 10,000$4,0000.01%
WADE G W & INC 80,000$30,0000.01%
Estate Counselors, LLC 10,000$4,0000.00%
SABBY MANAGEMENT, LLC 93,283$35,0000.00%
TWO SIGMA SECURITIES, LLC 11,466$4,0000.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$6,0000.00%
Tower Research Capital LLC (TRC) 27,451$10,0000.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders